Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$42.4M
5 rounds on record
Latest round
$22.1M
Venture round · Oct 2024 · 2 yr ago
Team
51-200
employees, estimated range
Grants
$3.1M
2 grants · CORDIS
The money's age
Due for its next round
24 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 22, 2024 Board appointment Peter Olagunju, Director · SEC Form D Sep 12, 2023 New executive Sarah Hein, Director, Executive Officer · SEC Form D 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Grant Jul 2025 $1.1M — CORDIS
Venture round Oct 2024 $22.1M — SEC Form D
Grant Sep 2024 $2M — CORDIS
Convertible Note Sep 2023 $8.9k — SEC Form D
Venture round Sep 2022 $20.3M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity March Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Fahim FarzadfardExecutive Officer, DirectorSEC Form D
Jeong Seuk KangExecutive Officer, DirectorSEC Form D
Sarah HeinDirector, Executive OfficerSEC Form D
Maksim MamonkinDirector, Executive OfficerSEC Form D

Overview

Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of.

People

Fahim Farzadfard
Executive Officer, Director
Jeong Seuk Kang
Executive Officer, Director
Sarah Hein
Director, Executive Officer
Maksim Mamonkin
Director, Executive Officer
Clare Ozawa
Director
Thomas Luby
Director
Peter Olagunju
Director
Joseph Petrosino
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Houston United States
HQ
50-200 est. staff

Financials

Total raised
$45.6M
Latest round
Grant
Funding rounds
5
Funding rounds
Round Announced Amount
Grant 2025 $1.1M Details
Venture - Series Unknown 2024 $22.1M Details
Grant 2024 $2M Details
Convertible Note 2023 $8.9k Details
Venture - Series Unknown 2022 $20.3M Details